Benefily

Cohere Health review: prior authorization automation examined

Benefily Team9 min read
A medical practitioner reviewing clinical information on a laptop and tablet at a desk

Photo: Thirdman on Pexels

A health plan drowning in prior authorization requests, and a provider group tired of faxing clinical notes into a black box: that's the gap Cohere Health says it fills. The Boston-based company sells AI-assisted software that reviews requests, approves the routine ones instantly, and routes the rest to a clinician. This review works through what Cohere Health has actually published about its platform, checks those claims against outside coverage where it exists, and flags what still isn't disclosed. It draws only on material the company and independent outlets have made public, not on marketing copy taken at face value.

Key takeaways

  • Cohere Health builds AI-assisted utilization management software used by health plans including Humana and Geisinger, and, since 2025, by CMS itself for a Medicare pilot.
  • The company publishes real turnaround-time and satisfaction figures from named partnerships, which is more transparency than many rivals offer.
  • Its Humana case study reports a median approval time of zero minutes and a 95% platform adoption rate for musculoskeletal requests across 12 states.
  • Cohere Health is one of six vendors CMS selected to run prior authorization for its WISeR Model in Original Medicare — a role that pays vendors partly based on savings identified, which is worth scrutinising.
  • Pricing, the identities of most health plan clients, and independent audits of its AI models remain undisclosed.
  • In our assessment, it's a credible, evidence-publishing player in a crowded field, not a proven, independently verified solution to prior authorization's problems.

What Cohere Health is

Cohere Health sells software to health plans, not to patients or, directly, to prescribers. Its platform sits inside a plan's utilization management operation: the unit that decides whether to pay for a requested treatment, medical service, or procedure. According to the company's own site, the product line has grown from prior authorization review into payment integrity, appeals handling, care management, and quality measurement, all built on what it calls a shared "clinical intelligence" layer.

The mechanics are straightforward on paper. A provider submits a request, either through Cohere's own portal or, since 2024, directly from Epic's EHR via Epic's Payer Platform. Cohere's system checks the request against the plan's medical policy and the patient's history. If the case is routine and clearly meets the policy, it approves automatically. If it doesn't, a nurse or physician reviewer takes over. Cohere Health states that roughly 85% of requests get a real-time decision this way, a claim that's consistent across several of its own pages, though it is the company's own figure rather than an independently audited one.

Who actually uses it

Two named partnerships give the clearest picture of Cohere Health in practice. Humana expanded its use of the platform nationally in 2021 after a nine-state pilot, and its chief medical officer at the time went on record about the results (see the quote below). Geisinger Health Plan partnered with Cohere in 2022 to run utilization management across several service lines. Beyond these two, the company says it serves 17 clients covering roughly 25 million lives and 420,000 providers, but it does not publish a full client list, so most of that reach is unverifiable from the outside.

The more consequential recent development is regulatory rather than commercial. In 2025, the Centers for Medicare & Medicaid Services named Cohere Health as one of six technology vendors running its WISeR Model, a pilot that applies AI-assisted prior authorization to a defined list of services in Original Medicare across several states, including Texas, where Cohere is the assigned vendor working through the Medicare administrative contractor Novitas. That's a genuinely different kind of validation: CMS chose Cohere to help administer a federal program, not just a commercial contract. It's also worth being precise about scope, since this site's focus is Medicare Part D drug coverage: WISeR covers medical services and procedures under Original Medicare, not Part D prescription drugs, so it sits adjacent to rather than inside this site's usual territory.

Published outcomes vs. open questions

The table below separates what Cohere Health (or a named partner) has put a specific, checkable figure on, from what remains vague, self-reported without detail, or simply undisclosed.

QuestionWhat's publicly documentedWhat's unclear or undisclosed
Decision speedHumana case study cites a median approval time of 0 minutes for 89% of requests in 12 states (2021 data)No company-wide, independently audited turnaround-time figure across all clients
Payer partnersHumana and Geisinger Health Plan named directly; CMS/Novitas named for the WISeR ModelFull list of the other ~15 named clients is not published
Clinical scopeMusculoskeletal, cardiovascular, sleep, imaging, gastrointestinal and sepsis pathways named on its siteHow coverage varies for Medicare Part D drug-specific prior authorization, this site's core subject, is not addressed in its published materials
Real-time vs. asynchronousCompany states ~85-90% of routine requests are auto-approved instantly; the rest go to clinical reviewersAverage wait time for the non-automated share is not broken out publicly
Independent scoringIncluded in Gartner's Hype Cycle listings and named in TIME's health-tech coverageNo published KLAS, G2, or Capterra customer-review score was found
PricingNot publishedEntirely undisclosed; likely negotiated per health-plan contract
What's publicly documented about Cohere Health versus what isn't.

The WISeR question worth sitting with

CMS pays WISeR vendors, Cohere Health included, in part based on the savings they identify from reducing what the program calls wasteful or inappropriate services. Healthcare finance commentators have pointed out that this creates an incentive structure worth watching closely: a vendor paid partly on denials avoided has a financial reason to deny more, not less. That's not an accusation against Cohere specifically, and no source we reviewed alleged that Cohere's own denial rate under WISeR is out of line. But it's a structural feature of the program Cohere is now part of, and it's more relevant to due diligence than any marketing claim on the company's own site.

Separately, physician groups have raised broader concerns this year about AI's role in prior authorization generally, including higher denial rates when automated systems review claims with little human oversight. We found no source naming Cohere Health specifically in that criticism, but it's the industry context any plan or provider group should hold in mind when reading a vendor's own performance figures.

In just nine months, the results of Cohere's digital authorization platform have exceeded our expectations.

Where it fits in a workflow

Picture a mid-sized regional health plan running its own utilization management team for physical therapy and imaging referrals. Today, a nurse reviewer manually checks each fax or portal submission against a policy document, and a backlog builds every Monday. If that plan deployed Cohere-style software, the bulk of routine, policy-clear requests, say, a standard MRI referral that matches diagnostic guidelines exactly, would clear automatically within minutes, with the reviewer's time redirected to the harder, ambiguous cases: unusual diagnoses, requests that partially meet policy, or ones flagged for a peer-to-peer conversation. This is an illustrative scenario built from how the company describes its own deployment model, not a real customer's account.

Questions to ask before adopting it

  • Ask for a client reference outside Humana and Geisinger. If the vendor can't produce one in your plan's size band or region, treat the published stats as illustrative rather than typical.
  • Ask exactly how the auto-approval rate is measured, and whether it's calculated per-request or weighted toward a handful of high-volume, low-complexity service lines like MSK imaging.
  • If you're a Medicare Advantage or Part D plan, ask directly how (or whether) the platform's drug-specific formulary logic differs from its medical-service logic, since almost all published case studies concern medical services, not prescription drugs.
  • Ask what independent audit, if any, has reviewed the AI models for denial-rate bias across demographic groups, and ask to see it rather than a summary.
  • If considering it for a WISeR-adjacent Medicare Advantage line, ask how the vendor's compensation is structured and whether it ties to savings or denial volume in any way.

Frequently asked questions

What does Cohere Health actually do?

It sells AI-assisted software to health plans that reviews prior authorization requests against medical policy, auto-approving routine cases and routing the rest to a human clinical reviewer. It also offers modules for payment integrity, appeals, and quality measurement.

Which health plans use Cohere Health?

Humana and Geisinger Health Plan are the two partnerships Cohere Health names directly on its own site and in press coverage. It states it serves 17 clients covering about 25 million members overall, but does not publish the full list.

Is Cohere Health involved in Medicare?

Yes, indirectly. CMS selected Cohere Health as one of six vendors administering its WISeR Model, a pilot applying AI-assisted prior authorization to certain services in Original Medicare in select states. That program covers medical services, not Medicare Part D prescription drugs.

Does Cohere Health publish an independent customer rating?

Not one we could verify. It appears in Gartner's Hype Cycle listings and health-tech media coverage, but no independently sourced G2, Capterra, or KLAS score was found in public materials as of this review.

How is Cohere Health different from a tool like CoverMyMeds?

CoverMyMeds mainly helps prescribers and pharmacies submit prior authorization paperwork to a plan. Cohere Health sells to the plan side instead, building the review and decisioning engine that receives and processes those requests.

Related on Benefily

Sources

Administrative information only. Benefily reports what a payer has published in its own prior-authorization policy as of the effective date shown. It is not medical advice, not a coverage or payment guarantee, and not an authorization. Requirements vary by plan, place of service and member benefits — always verify with the payer before rendering service.

More from Reviews